MRC Study of carcinoma in situ of the contralateral testis

Completed

• Conditions: Cancer; Testicular cancer

• Registration Number: ISRCTN37957513
• Lead Sponsor: Medical Research Council (MRC) (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2001-02-08
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 208

Inclusion Criteria

1. Germ cell tumour of testis or history of one having been excised in the previous five years
2. History of maldescent
3. Volume of 12 ml or less in remaining testis

Exclusion Criteria

Previous chemotherapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified